HC Wainwright Forecasts electroCore FY2030 Earnings

electroCore, Inc. (NASDAQ:ECOR) – Stock analysts at HC Wainwright issued their FY2030 earnings per share estimates for electroCore in a note issued to investors on Monday, January 26th. HC Wainwright analyst S. Ramakanth expects that the company will earn $0.90 per share for the year. HC Wainwright has a “Buy” rating and a $18.00 price objective on the stock. The consensus estimate for electroCore’s current full-year earnings is ($1.49) per share.

Several other research analysts also recently issued reports on ECOR. Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research report on Monday, December 29th. Wall Street Zen raised electroCore from a “sell” rating to a “hold” rating in a research report on Saturday, November 8th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, electroCore presently has a consensus rating of “Hold” and an average price target of $22.00.

electroCore Price Performance

Shares of NASDAQ ECOR opened at $7.25 on Tuesday. The firm’s 50-day moving average is $5.42 and its two-hundred day moving average is $5.48. The company has a market capitalization of $58 million, a PE ratio of -4.24 and a beta of 0.34. electroCore has a 12-month low of $4.16 and a 12-month high of $19.49.

electroCore (NASDAQ:ECOR) last released its quarterly earnings data on Wednesday, November 5th. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.07). The business had revenue of $8.69 million during the quarter, compared to analysts’ expectations of $7.84 million. electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%.

Institutional Investors Weigh In On electroCore

Several hedge funds have recently made changes to their positions in ECOR. FNY Investment Advisers LLC purchased a new stake in shares of electroCore in the fourth quarter valued at $82,000. Two Sigma Investments LP boosted its stake in electroCore by 20.8% in the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after buying an additional 4,231 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in electroCore in the 1st quarter valued at about $153,000. Jaffetilchin Investment Partners LLC increased its stake in shares of electroCore by 26.7% during the 2nd quarter. Jaffetilchin Investment Partners LLC now owns 41,783 shares of the company’s stock valued at $221,000 after acquiring an additional 8,800 shares during the last quarter. Finally, Jane Street Group LLC increased its stake in shares of electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after acquiring an additional 19,599 shares during the last quarter. Institutional investors and hedge funds own 26.74% of the company’s stock.

Trending Headlines about electroCore

Here are the key news stories impacting electroCore this week:

• Positive Sentiment: HC Wainwright kept a “Buy” rating and an $18.00 price target on ECOR, and made a small upward tweak to FY2025 (-$1.62 from -$1.63), which provides some medium‑term support despite cuts to other years. HC Wainwright note
• Neutral Sentiment: Reported short interest data for January shows “0” shares and a 0.0 days short‑interest ratio — this appears to be a data anomaly or indicates no concentrated short positioning; it’s not providing meaningful upward or downward pressure today.
• Neutral Sentiment: There is an article about “Ecora Royalties” (ticker ECOR on other exchanges) in market headlines; that company is unrelated to electroCore (NASDAQ: ECOR) and can be ignored for equity moves in the U.S. listing. Ecora Royalties trading update
• Negative Sentiment: HC Wainwright issued a series of downward revisions across 2026 quarters and later years (Q1–Q4 2026 and FY2026–FY2029), including a large cut to FY2026 EPS (to -$1.65 from a prior $0.32) and much lower near‑term quarterly forecasts — this materially weakens near‑term profitability expectations and is the likely primary cause of today’s sell‑off. HC Wainwright revisions

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.